Laser/sensitizer assisted immunotherapy
US6149671A · kind A · utility
37Cited by
19References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 1997 |
| Grant date | Nov 21, 2000 |
| Priority date | — |
| Expiry date | Nov 7, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08L5/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a neoplasm, such as a malignant tumor, in humans and other animals, is disclosed. A chromophore and an immunoadjuvant are introduced into the neoplasm. The neoplasm is then lased at an irradiance sufficient to induce neoplastic cellular destruction and to stimulate the self-immunological defense system against neoplastic cellular multiplication.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.